• Email contact@txcro.com
  • Call Now + (86) - 1709 100 0163
  • 15 03 2024

Development and Testing of Flow Cytometer Peripheral Blood Sample Collection Project

Study Name: Development and Testing of Flow Cytometer Peripheral Blood Sample Collection Project
Site: Suzhou Science and Technology City Hospital
Sponsor: BD Shanghai
HGRAC Approval Time: January 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

  • 15 03 2024

Study on Physiological-Guided Machine Learning Methods for Precise Typing of Heart Failure with Preserved Ejection Fraction (HFpEF)

Study Name: Study on Physiological-Guided Machine Learning Methods for Precise Typing of Heart Failure with Preserved Ejection Fraction (HFpEF)
Site: Peking University Third Hospital (Peking University Third Clinical Medical College)
Sponsor: University of Michigan
HGRAC Approval Time: January 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

  • 15 03 2024

Prospective, Single-Center, Exploratory Study to Evaluate the Feasibility and Safety of Transcatheter Mitral Valve Clip and Delivery System in Treating Moderate to Severe Primary Mitral Regurgitation

Study Name: Prospective, Single-Center, Exploratory Study to Evaluate the Feasibility and Safety of Transcatheter Mitral Valve Clip and Delivery System in Treating Moderate to Severe Primary Mitral Regurgitation
Site: The First Hospital of Hebei Medical University
Sponsor: Shanghai MicroPort CardioFlow Medtech 
HGRAC Approval Time: January 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

  • 15 03 2024

Artificial Intelligence Methods and Applications in the Diagnosis and Treatment of Breast Cancer in Clinical Settings

Study Name: Artificial Intelligence Methods and Applications in the Diagnosis and Treatment of Breast Cancer in Clinical Settings
Site: Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Third-Party Lab: Sun Yat-sen University, Beiming Software Co., Ltd., City University of Hong Kong
HGRAC Approval Time: January 2024

  • 15 03 2024

Clinical Study of Helicobacter pylori Nucleic Acid Test Kit (Digital PCR Method)

Study Name: Clinical Study of Helicobacter pylori Nucleic Acid Test Kit (Digital PCR Method)
Site: Qingyuan People's Hospital
Sponsor: Shenzhen MedCaptain 
HGRAC Approval Time: February 2024

  • 15 03 2024

Clinical Study of Human HER2 Gene Amplification Test Kit (Digital PCR Method)

Study Name: Clinical Study of Human HER2 Gene Amplification Test Kit (Digital PCR Method)
Site: Qingyuan People's Hospital
Sponsor: Shenzhen MedCaptain 
HGRAC Approval Time: February 2024

  • 15 03 2024

Clinical Research on Reference Interval Establishment of Thyroglobulin Assay Kit (Chemiluminescence Method)

Study Name: Clinical Research on Reference Interval Establishment of Thyroglobulin Assay Kit (Chemiluminescence Method)
Site: Beijing Huaxin Hospital (First Affiliated Hospital of Tsinghua University)
Sponsor: Beckman Coulter 
HGRAC Approval Time: February 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

  • 15 03 2024

Evaluation of Embotrap Retrieval and Thrombus Assessment in Cerebrovascular Mechanical Thrombectomy

Study Name: Evaluation of Embotrap Retrieval and Thrombus Assessment in Cerebrovascular Mechanical Thrombectomy
Site: Xuanwu Hospital, Capital Medical University (Beijing Geriatric Health and Disease Prevention Center, Beijing Institute of Functional Neurosurgery)
Sponsor: Johnson & Johnson Medical Equipment (Shanghai) Co., Ltd., Depuy Synthes Products, Inc.
HGRAC Approval Time: February 2024
Note: HGRAC Approval or Filing (Human Genetic Resource Administration of China) is an important step before the first enrollment of subjects for clinical trials in China sponsored by foreign companies.

  • 15 03 2024

Comparative Analysis of Immune Cells in the Tumor Microenvironment of Colorectal Cancer Based on Single-Cell Sequencing

Study Name: Comparative Analysis of Immune Cells in the Tumor Microenvironment of Colorectal Cancer Based on Single-Cell Sequencing
Site: Beijing Cancer Prevention and Research Institute
HGRAC Approval Time: February 2024

  • 15 03 2024

Prospective, Single-Center, Single-Arm, Open Clinical Study to Evaluate the Safety and Effectiveness of Artificial Cornea for Treating Corneal Diseases Requiring Lamellar Transplantation Surgery in Corneal Transplant Patients

Study Name: Prospective, Single-Center, Single-Arm, Open Clinical Study to Evaluate the Safety and Effectiveness of Artificial Cornea for Treating Corneal Diseases Requiring Lamellar Transplantation Surgery in Corneal Transplant Patients
Site: Tongji Medical College, Huazhong University of Science and Technology, Union Hospital
Sponsor: Xiwel (Suzhou) Biomedical Technology Co., Ltd.
HGRAC Approval Time: February 2024